We are live on
!
Find out more
Edwards Lifesciences
1,226 hedge funds and large institutions have $37.6B invested in Edwards Lifesciences in 2024 Q4 according to their latest regulatory filings, with 191 funds opening new positions, 353 increasing their positions, 500 reducing their positions, and 140 closing their positions.
New
Increased
Maintained
Reduced
Closed
122% more call options, than puts
Call options by funds: $586M | Put options by funds: $264M
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
36% more first-time investments, than exits
New positions opened: 191 | Existing positions closed: 140
18% more capital invested
Capital invested by funds: $31.9B → $37.6B (+$5.67B)
5.17% more ownership
Funds ownership: 80.08% → 85.24% (+5.2%)
3% more funds holding
Funds holding: 1,193 → 1,226 (+33)
29% less repeat investments, than reductions
Existing positions increased: 353 | Existing positions reduced: 500
Holders
1,226
Holders Change
+33
Holders Change %
+2.77%
% of All Funds
16.15%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
191
Increased
353
Reduced
500
Closed
140
Calls
$586M
Puts
$264M
Net Calls
+$322M
Net Calls Change
-$115M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$526M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$520M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$458M |
| 4 |
JP Morgan Chase
New York
|
+$447M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$245M |
